GENE ONLINE|News &
Is Exosome the Next Rising Star?
The exosome diagnostics and therapeutics market was valued at US$ 46 million in 2019 and is expected to reach US$ 617 million by 2027 with a CAGR of 38%. The global growth mainly results from the rising prevalence of chronic diseases and incidence of cancer.
Currently, there are still some challenges ahead that need to overcome in the future. This includes the validation and standardization for the exosome and the heavy investment in manufacturing, research, and development activities.
Currently, there are still some challenges ahead that need to overcome in the future. This includes the validation and standardization for the exosome and the heavy investment in manufacturing, research, and development activities.
GO Prime with only $1.49 now
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
